Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.1850
+0.0100 (5.71%)
May 29, 2026, 4:10 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 111.07 million as of May 29, 2026. Its market cap has decreased by -65.72% in one year.
Market Cap
111.07M
Enterprise Value
72.62M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 111.07M, an increase of 739.15%. That is a compound annual growth rate of 21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 105.07M | -68.18% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 164.83M |
| Actinogen Medical | 136.47M |
| Nyrada | 127.37M |
| Island Pharmaceuticals | 116.89M |
| Alterity Therapeutics | 97.88M |
| Paradigm Biopharmaceuticals | 91.95M |
| Arovella Therapeutics | 87.03M |
| Prescient Therapeutics | 82.02M |